{"id":"https://openalex.org/W2889730271","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.e16529","title":"A Phase II Study of the Dual mTOR Inhibitor MLN0128 in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC).","display_name":"A Phase II Study of the Dual mTOR Inhibitor MLN0128 in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC).","publication_year":2016,"publication_date":"2016-05-20","ids":{"openalex":"https://openalex.org/W2889730271","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.e16529","mag":"2889730271"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2016.34.15_suppl.e16529","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.e16529","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2016.34.15_suppl.e16529","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002358672","display_name":"Dana E. Rathkopf","orcid":"https://orcid.org/0000-0002-4503-7582","observed_orcids":["https://orcid.org/0000-0002-4503-7582"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dana E. Rathkopf","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039147214","display_name":"Susan F. Slovin","orcid":"https://orcid.org/0000-0002-9074-9191","observed_orcids":["https://orcid.org/0000-0002-9074-9191"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan F. Slovin","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090778997","display_name":"Karen A. Autio","orcid":"https://orcid.org/0000-0003-0720-0390","observed_orcids":["https://orcid.org/0000-0003-0720-0390"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen A. Autio","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080063370","display_name":"A. Delacruz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony Delacruz","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034984714","display_name":"Gregory Shelkey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory Shelkey","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078077400","display_name":"Katherine Pisano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katherine Pisano","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073950712","display_name":"Melanie A. Hullings","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melanie Hullings","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049015886","display_name":"Mia DeNunzio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mia DeNunzio","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017288060","display_name":"Michael J. Morris","orcid":"https://orcid.org/0000-0002-9454-0096","observed_orcids":["https://orcid.org/0000-0002-9454-0096"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael J. Morris","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072850546","display_name":"Howard I. Scher","orcid":"https://orcid.org/0000-0002-6791-9324","observed_orcids":["https://orcid.org/0000-0002-6791-9324"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Howard I. Scher","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1334819555"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"34","issue":"15_suppl","first_page":"e16529","last_page":"e16529"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mln0128","display_name":"MLN0128","score":0.9800000190734863},{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.9629999995231628},{"id":"https://openalex.org/keywords/abiraterone-acetate","display_name":"abiraterone","score":0.7160000205039978},{"id":"https://openalex.org/keywords/enzalutamide","display_name":"enzalutamide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8460000157356262},{"id":"https://openalex.org/keywords/psa-response","display_name":"PSA response","score":0.6470000147819519},{"id":"https://openalex.org/keywords/circulating-tumor-cells","display_name":"circulating tumor cells","score":0.9390000104904175},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.5839999914169312},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.6079999804496765},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.5210000276565552},{"id":"https://openalex.org/keywords/maculopapular-rash","display_name":"maculopapular rash","score":0.6309999823570251}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.888884961605072},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.7022601366043091},{"id":"https://openalex.org/C2776551883","wikidata":"https://www.wikidata.org/wiki/Q1996756","display_name":"Enzalutamide","level":5,"score":0.699569582939148},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.6656973361968994},{"id":"https://openalex.org/C2775832370","wikidata":"https://www.wikidata.org/wiki/Q27888393","display_name":"Abiraterone acetate","level":5,"score":0.6246408224105835},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.6145313382148743},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4602590501308441},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.43107306957244873},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4248838424682617},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3506871461868286},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34307989478111267},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3409144878387451},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2544315457344055},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.15776243805885315},{"id":"https://openalex.org/C2777899217","wikidata":"https://www.wikidata.org/wiki/Q4759439","display_name":"Androgen deprivation therapy","level":4,"score":0.10836878418922424}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2016.34.15_suppl.e16529","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.e16529","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2016.34.15_suppl.e16529","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2789943575","https://openalex.org/W1993324577","https://openalex.org/W2979304494","https://openalex.org/W2804105285","https://openalex.org/W2590235991","https://openalex.org/W2590602908","https://openalex.org/W2509562570","https://openalex.org/W4361253222","https://openalex.org/W4388794355","https://openalex.org/W2601659212"],"abstract_inverted_index":{"e16529":[0],"Background:":[1],"MLN0128":[2,39,65,98],"is":[3,239],"a":[4,127,150,179,186],"first-in-class,":[5],"dual":[6,360],"mTOR":[7,361],"inhibitor":[8],"that":[9],"has":[10],"the":[11,35,120,167,300,306,342],"potential":[12],"to":[13,33,78,89,265,287,291,310,336,359,365],"overcome":[14],"resistance":[15],"seen":[16],"with":[17,46,50,104,126,149,185,375],"standard":[18],"rapalogs":[19],"through":[20],"inhibition":[21],"of":[22,38,130,155,162,188,194,207,218,223,232,280,299,347,354],"both":[23],"TORC1":[24],"and":[25,82,139,196,254,271,322,339,350,369],"TORC2.":[26],"This":[27],"phase":[28,344],"II":[29],"study":[30,281],"was":[31,60,111,173],"designed":[32],"evaluate":[34],"anti-tumor":[36],"activity":[37],"in":[40,181,357,379],"mCRPC":[41,47],".":[42],"Methods:":[43],"Patients":[44],"(pts)":[45],"previously":[48],"treated":[49],"abiraterone":[51],"acetate":[52],"(AA)":[53],"and/or":[54],"enzalutamide":[55],"(ENZ).":[56],"Prior":[57],"docetaxel":[58],"(Doc)":[59],"allowed.":[61],"5":[62,67,197,227,274,348],"pts":[63,84,94,135,164,177,198,234,275,302,331],"started":[64,96,277],"at":[66,99,114,341],"mg":[68,101],"po":[69,80,91,102],"once":[70,77],"daily":[71,283,289],"(qd),":[72],"all":[73],"were":[74,95,147,267,284,332],"dose":[75,86,106,285,346],"reduced":[76,87,286],"4mg":[79,288],"qd":[81,103],"2":[83,125,246,345],"subsequently":[85],"again":[88],"3mg":[90],"qd.":[92],"4":[93,100,144],"on":[97,153,183,278,371],"no":[105],"reductions.":[107],"The":[108,170,241,258],"primary":[109],"endpoint":[110,308],"progression-free":[112],"survival":[113],"6":[115],"months":[116],"as":[117],"defined":[118],"by":[119,382],"Prostate":[121],"Cancer":[122],"Working":[123],"Group":[124],"planned":[128],"accrual":[129],"21-42":[131],"pts.":[132],"Results:":[133],"9":[134,163,233,301,330],"(8":[136],"post":[137,142,145,228],"AA":[138],"ENZ,":[140,143],"1":[141,160],"Doc)":[146],"enrolled":[148],"median":[151,187],"time":[152],"treatment":[154,184,266,304],"11":[156],"weeks":[157],"(3-30":[158],"weeks).":[159],"out":[161,231],"(11%)":[165],"achieved":[166],"trial":[168,307,368,388],"endpoint.":[169],"best":[171],"response":[172,338,358],"stable":[174],"disease.":[175],"All":[176,273,329],"had":[178,200,210,235],"rise":[180],"PSA":[182,203,351],"159%":[189],"increase":[190],"from":[191],"baseline":[192,213],"(range":[193],"12-620%)":[195],"(56%)":[199],"an":[201,211],"immediate":[202],"decline":[204],"following":[205],"discontinuation":[206],"drug.":[208],"Pts":[209],"average":[212],"circulating":[214],"tumor":[215],"cell":[216],"count":[217],"51.4":[219],"cells/7.5ml":[220],"(2-401),":[221],"none":[222],"which":[224],"converted":[225],"\u2264":[226,245],"treatment.":[229],"7":[230],"matched":[236],"biopsies,":[237],"analysis":[238],"ongoing.":[240],"most":[242,259],"common":[243,260],"grade":[244,268,316],"adverse":[247,262],"events":[248,263],"were:":[249],"fatigue":[250],"(89%),":[251],"anorexia":[252],"(78%),":[253],"maculopapular":[255],"rash":[256],"(67%).":[257],"serious":[261],"related":[264],"3":[269,317],"dyspnea":[270],"rash.":[272],"who":[276],"5mg":[279],"drug":[282],"due":[290,309],"rash,":[292],"fatigue,":[293],"oral":[294],"mucositis":[295],"or":[296],"diarrhea.":[297],"8":[298],"discontinued":[303],"before":[305],"radiographic":[311],"progression":[312],"(n":[313,319,325],"=":[314,320,326],"2),":[315],"toxicity":[318],"4)":[321],"investigator":[323],"discretion":[324],"3).":[327],"Conclusions:":[328],"heavily":[333],"pretreated.":[334],"Due":[335],"limited":[337],"tolerance":[340],"recommended":[343],"mg,":[349],"kinetics":[352],"suggestive":[353],"AR":[355],"activation":[356,374],"inhibition,":[362],"we":[363],"elected":[364],"close":[366],"this":[367],"focus":[370],"reciprocal":[372],"feedback":[373],"combined":[376],"AR/PI3K":[377],"therapy":[378],"mCRPC.":[380],"Supported":[381],"Millennium":[383],"Pharmaceuticals,":[384],"SPORE":[385],"CA092629.":[386],"Clinical":[387],"information:":[389],"NCT02091531.":[390]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2018-09-27T00:00:00"}